Cite
Predicting the response to anti-PD1 therapy in metastatic melanoma
MLA
Lucie Heinzerling, et al. “Predicting the Response to Anti-PD1 Therapy in Metastatic Melanoma.” Translational Cancer Research, vol. 5, Sept. 2016, pp. S576–79. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........4dbe5a60f805b18448a0f0655b5cc550&authtype=sso&custid=ns315887.
APA
Lucie Heinzerling, Michael Constantin Kirchberger, Lisa Walter, & Gerold Schuler. (2016). Predicting the response to anti-PD1 therapy in metastatic melanoma. Translational Cancer Research, 5, S576–S579.
Chicago
Lucie Heinzerling, Michael Constantin Kirchberger, Lisa Walter, and Gerold Schuler. 2016. “Predicting the Response to Anti-PD1 Therapy in Metastatic Melanoma.” Translational Cancer Research 5 (September): S576–79. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........4dbe5a60f805b18448a0f0655b5cc550&authtype=sso&custid=ns315887.